Comet Biorefining
Comet Biorefining is an award-winning food technology company based in London, Ontario and Schaumburg, Illinois. The company makes unique, healthy and sustainable products using its patented upcycling technology. Its Arrabina(TM) Arabinoxylan Plant Fiber Extract has superior tolerability and functionality within the prebiotic market.
Sector
Industrial Biotech
Strategy
Industrial Biotech
Status
Live
Website
comet-bio.com
Related News
Comet Bio Announces $22M Round of Equity Financing
Comet Bio Wins “Start-Up of the Year” NutraIngredients Award for 2020
Comet Bio Announces Positive Clinical Trial Results for its Prebiotic Arrabina™
Comet Bio Completes Equity Financing and Opens U.S. Headquarters in Chicagoland Area
Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.